291 related articles for article (PubMed ID: 20171192)
1. Formation of parkin aggregates and enhanced PINK1 accumulation during the pathogenesis of Parkinson's disease.
Um JW; Park HJ; Song J; Jeon I; Lee G; Lee PH; Chung KC
Biochem Biophys Res Commun; 2010 Mar; 393(4):824-8. PubMed ID: 20171192
[TBL] [Abstract][Full Text] [Related]
2. Molecular interaction between parkin and PINK1 in mammalian neuronal cells.
Um JW; Stichel-Gunkel C; Lübbert H; Lee G; Chung KC
Mol Cell Neurosci; 2009 Apr; 40(4):421-32. PubMed ID: 19167501
[TBL] [Abstract][Full Text] [Related]
3. [Animal models for familial Parkinson's disease].
Takahashi R
Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
[TBL] [Abstract][Full Text] [Related]
4. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
Rakovic A; Grünewald A; Seibler P; Ramirez A; Kock N; Orolicki S; Lohmann K; Klein C
Hum Mol Genet; 2010 Aug; 19(16):3124-37. PubMed ID: 20508036
[TBL] [Abstract][Full Text] [Related]
5. Parkin stabilizes PINK1 through direct interaction.
Shiba K; Arai T; Sato S; Kubo S; Ohba Y; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2009 Jun; 383(3):331-5. PubMed ID: 19358826
[TBL] [Abstract][Full Text] [Related]
6. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
Wang C; Ko HS; Thomas B; Tsang F; Chew KC; Tay SP; Ho MW; Lim TM; Soong TW; Pletnikova O; Troncoso J; Dawson VL; Dawson TM; Lim KL
Hum Mol Genet; 2005 Dec; 14(24):3885-97. PubMed ID: 16278233
[TBL] [Abstract][Full Text] [Related]
7. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.
Vercammen L; Van der Perren A; Vaudano E; Gijsbers R; Debyser Z; Van den Haute C; Baekelandt V
Mol Ther; 2006 Nov; 14(5):716-23. PubMed ID: 16914382
[TBL] [Abstract][Full Text] [Related]
8. Loss-of-function rodent models for parkin and PINK1.
Oliveras-Salvá M; Van Rompuy AS; Heeman B; Van den Haute C; Baekelandt V
J Parkinsons Dis; 2011; 1(3):229-51. PubMed ID: 23939304
[TBL] [Abstract][Full Text] [Related]
9. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
Im E; Chung KC
J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
[TBL] [Abstract][Full Text] [Related]
10. Maackiain Ameliorates 6-Hydroxydopamine and
Tsai RT; Tsai CW; Liu SP; Gao JX; Kuo YH; Chao PM; Hung HS; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585871
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of PARK2 splice isoforms in an in vitro model of dopaminergic-like neurons exposed to toxic insults mimicking Parkinson's disease.
La Cognata V; Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Biochem; 2018 Jan; 119(1):1062-1073. PubMed ID: 28688199
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
13. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial E3 Ubiquitin Ligase Parkin: Relationships with Other Causal Proteins in Familial Parkinson's Disease and Its Substrate-Involved Mouse Experimental Models.
Torii S; Kasai S; Yoshida T; Yasumoto KI; Shimizu S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054064
[TBL] [Abstract][Full Text] [Related]
15. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.
Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O
Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737
[TBL] [Abstract][Full Text] [Related]
16. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
17. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
Dodson MW; Guo M
Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
[TBL] [Abstract][Full Text] [Related]
18. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM
J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723
[TBL] [Abstract][Full Text] [Related]
19. [Molecular genetics of PINK1].
Funayama M; Hattori N
Brain Nerve; 2007 Aug; 59(8):831-8. PubMed ID: 17713119
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling.
Sha D; Chin LS; Li L
Hum Mol Genet; 2010 Jan; 19(2):352-63. PubMed ID: 19880420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
